WIM
IRLA

Westside Investment Management’s IRulya Therapeutics Inc. Common Stock IRLA Stock Holding History

Westside Investment Management’s Portfolio IRLA Stock Details IRLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18 Buy
+1
New +$23 ﹤0.01% 1437
2026
Q1 		– Hold
0
– – – 1470
2025
Q4 		– Hold
0
– – – 1465
2025
Q3 		– Hold
0
– – – 1368
2025
Q2 		– Hold
0
– – – 1270
2025
Q1 		– Hold
0
– – – 968
2024
Q4 		– Hold
0
– – – 972
2024
Q3 		– Hold
0
– – – 981
2024
Q2 		– Hold
0
– – – 976
2024
Q1 		– Hold
0
– – – 889
2023
Q4 		– Hold
0
– – – 857
2023
Q3 		– Hold
0
– – – 830
2023
Q2 		– Hold
0
– – – 828
2023
Q1 		– Hold
0
– – – 826
2022
Q4 		– Hold
0
– – – 842
2022
Q3 		– Hold
0
– – – 843
2022
Q2 		– Hold
0
– – – 830
2022
Q1 		– Hold
0
– – – 807
2021
Q4 		– Hold
0
– – – 789
2021
Q3 		– Hold
0
– – – 633
2021
Q2 		– Hold
0
– – – 696
2021
Q1 		– Hold
0
– – – 688
2020
Q4 		– Hold
0
– – – 612
2020
Q3 		– Hold
0
– – – 596

Other funds holding IRLA

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Westside Investment Management's IRLA Position: Q2 2026 in Review

Westside Investment Management opened a new position in IRulya Therapeutics Inc. Common Stock (IRLA) in Q2 2026: 1 share worth $18. The stake represents ﹤0.01% of the portfolio and ranks #1437 among its holdings.

26 funds tracked by Wall St. Rank hold IRLA as of Q2 2026.

  • Westside Investment Management held 1 share of IRulya Therapeutics Inc. Common Stock worth $18 as of Q2 2026.
  • IRulya Therapeutics Inc. Common Stock was a new Westside Investment Management position in Q2 2026.
  • IRulya Therapeutics Inc. Common Stock made up ﹤0.01% of Westside Investment Management's portfolio in Q2 2026, its #1437 holding.
  • 26 funds tracked by Wall St. Rank held IRulya Therapeutics Inc. Common Stock as of Q2 2026.

Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.